Market Place
Sourcing Support
All News #Library
Biotech
Obsidian to Present OBX-115 Phase 2 Melanoma Data at ASCO
21 Apr 2026 //
BUSINESSWIRE
Obsidian Leverages Galera Reverse Merger To Go Public
14 Apr 2026 //
FIERCE BIOTECH
Obsidian Therapeutics Names Julie Feder as CFO
12 Jan 2026 //
PHARMIWEB
Obsidian Therapeutics Reports Positive Data on OBX-115 at ASCO
02 Jun 2025 //
BUSINESSWIRE
Obsidian Therapeutics to Present Preclinical Data at ASGCT Meeting
28 Apr 2025 //
BUSINESSWIRE
Obsidian Therapeutics Presents at AACR Annual Meeting
25 Apr 2025 //
BUSINESSWIRE
Obsidian Therapeutics to Present Clinical Data on OBX-115 at 2025
23 Apr 2025 //
BUSINESSWIRE
Obsidian Therapeutics to Present at 43rd J.P. Morgan Conference
06 Jan 2025 //
BUSINESSWIRE
Obsidian to Present OBX-115 & cytoDRiVE® Data at SITC 2024
05 Nov 2024 //
BUSINESSWIRE
Obsidian`s OBX-115 Safety, Efficacy Data In ASCO Oral Presentation
03 Jun 2024 //
BUSINESSWIRE
Obsidian Obx-115 Melanoma Positive: Advanced Patient Data Asco 2024
23 May 2024 //
BUSINESSWIRE
Obsidian Announces Positive Interim Top-Line Clinical Data for OBX-115
12 Dec 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.